| Year |
Citation |
Score |
| 2020 |
Kane CJM, Drew PD. Neuroinflammatory contribution of microglia and astrocytes in fetal alcohol spectrum disorders. Journal of Neuroscience Research. PMID 32959429 DOI: 10.1002/Jnr.24735 |
0.361 |
|
| 2017 |
Chen J, Martindale JL, Cramer C, Gorospe M, Atasoy U, Drew PD, Yu S. The RNA-binding protein HuR contributes to neuroinflammation by promoting C-C chemokine receptor 6 (CCR6) expression on Th17 cells. The Journal of Biological Chemistry. PMID 28684423 DOI: 10.1074/Jbc.M117.782771 |
0.374 |
|
| 2017 |
Cippitelli A, Domi E, Ubaldi M, Douglas JC, Li HW, Demopulos G, Gaitanaris G, Roberto M, Drew PD, Kane CJ, Ciccocioppo R. Protection against alcohol-induced neuronal and cognitive damage by the PPARγ receptor agonist pioglitazone. Brain, Behavior, and Immunity. PMID 28167117 DOI: 10.1016/J.Bbi.2017.02.001 |
0.324 |
|
| 2016 |
Drew PD, Kane CJ. Peroxisome Proliferator-Activated Receptor-γ Agonists: Potential Therapeutics for Neuropathology Associated with Fetal Alcohol Spectrum Disorders. Journal of Clinical & Cellular Immunology. 7. PMID 28203487 DOI: 10.4172/2155-9899.1000469 |
0.374 |
|
| 2016 |
Kane CJ, Drew PD. Inflammatory responses to alcohol in the CNS: nuclear receptors as potential therapeutics for alcohol-induced neuropathologies. Journal of Leukocyte Biology. PMID 27462100 DOI: 10.1189/Jlb.3Mr0416-171R |
0.329 |
|
| 2015 |
Odle AK, Drew PD, Childs GV. Giant mice reveal new roles for GH in regulating the adipose immune microenvironment. Endocrinology. 156: 1613-5. PMID 25886070 DOI: 10.1210/En.2015-1205 |
0.317 |
|
| 2015 |
Drew PD, Johnson JW, Douglas JC, Phelan KD, Kane CJ. Pioglitazone blocks ethanol induction of microglial activation and immune responses in the hippocampus, cerebellum, and cerebral cortex in a mouse model of fetal alcohol spectrum disorders. Alcoholism, Clinical and Experimental Research. 39: 445-54. PMID 25703036 DOI: 10.1111/Acer.12639 |
0.304 |
|
| 2014 |
Drew PD, Kane CJ. Fetal alcohol spectrum disorders and neuroimmune changes. International Review of Neurobiology. 118: 41-80. PMID 25175861 DOI: 10.1016/B978-0-12-801284-0.00003-8 |
0.34 |
|
| 2014 |
Xie L, Chen J, McMickle A, Awar N, Nady S, Sredni B, Drew PD, Yu S. The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 273: 31-41. PMID 24975323 DOI: 10.1016/J.Jneuroim.2014.05.015 |
0.387 |
|
| 2014 |
Kane CJ, Phelan KD, Douglas JC, Wagoner G, Johnson JW, Xu J, Phelan PS, Drew PD. Effects of ethanol on immune response in the brain: region-specific changes in adolescent versus adult mice. Alcoholism, Clinical and Experimental Research. 38: 384-91. PMID 24033454 DOI: 10.1111/Acer.12244 |
0.365 |
|
| 2013 |
Kane CJ, Phelan KD, Douglas JC, Wagoner G, Johnson JW, Xu J, Drew PD. Effects of ethanol on immune response in the brain: region-specific changes in aged mice. Journal of Neuroinflammation. 10: 66. PMID 23701841 DOI: 10.1186/1742-2094-10-66 |
0.302 |
|
| 2013 |
Xu J, Wagoner G, Douglas JC, Drew PD. β-Lapachone ameliorization of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 254: 46-54. PMID 23010281 DOI: 10.1016/J.Jneuroim.2012.09.004 |
0.382 |
|
| 2012 |
Wight RD, Tull CA, Deel MW, Stroope BL, Eubanks AG, Chavis JA, Drew PD, Hensley LL. Resveratrol effects on astrocyte function: relevance to neurodegenerative diseases. Biochemical and Biophysical Research Communications. 426: 112-5. PMID 22917537 DOI: 10.1016/J.Bbrc.2012.08.045 |
0.422 |
|
| 2012 |
Burns SA, Lee Archer R, Chavis JA, Tull CA, Hensley LL, Drew PD. Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis. Brain Research. 1473: 236-41. PMID 22884503 DOI: 10.1016/J.Brainres.2012.07.054 |
0.433 |
|
| 2011 |
Solt LA, Kumar N, Nuhant P, Wang Y, Lauer JL, Liu J, Istrate MA, Kamenecka TM, Roush WR, Vidovi? D, Schürer SC, Xu J, Wagoner G, Drew PD, Griffin PR, et al. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature. 472: 491-4. PMID 21499262 DOI: 10.1038/Nature10075 |
0.345 |
|
| 2011 |
Kane CJ, Phelan KD, Han L, Smith RR, Xie J, Douglas JC, Drew PD. Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists. Brain, Behavior, and Immunity. 25: S137-45. PMID 21376806 DOI: 10.1016/J.Bbi.2011.02.016 |
0.362 |
|
| 2009 |
Racke MK, Drew PD. Toll-like receptors in multiple sclerosis. Current Topics in Microbiology and Immunology. 336: 155-68. PMID 19688333 DOI: 10.1007/978-3-642-00549-7_9 |
0.358 |
|
| 2009 |
Xu J, Wagoner G, Douglas JC, Drew PD. Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity. Journal of Leukocyte Biology. 86: 401-9. PMID 19406833 DOI: 10.1189/Jlb.1008600 |
0.387 |
|
| 2009 |
Gocke AR, Hussain RZ, Yang Y, Peng H, Weiner J, Ben LH, Drew PD, Stuve O, Lovett-Racke AE, Racke MK. Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease. Journal of Immunology (Baltimore, Md. : 1950). 182: 4479-87. PMID 19299749 DOI: 10.4049/Jimmunol.0713927 |
0.334 |
|
| 2008 |
Racke MK, Drew PD. PPARs in Neuroinflammation. Ppar Research. 2008: 638356. PMID 18682822 DOI: 10.1155/2008/638356 |
0.405 |
|
| 2008 |
Yang Y, Gocke AR, Lovett-Racke A, Drew PD, Racke MK. PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis. Ppar Research. 2008: 546753. PMID 18645614 DOI: 10.1155/2008/546753 |
0.367 |
|
| 2008 |
Xu J, Barger SW, Drew PD. The PPAR-gamma Agonist 15-Deoxy-Delta-Prostaglandin J(2) Attenuates Microglial Production of IL-12 Family Cytokines: Potential Relevance to Alzheimer's Disease. Ppar Research. 2008: 349185. PMID 18615183 DOI: 10.1155/2008/349185 |
0.372 |
|
| 2008 |
Drew PD, Xu J, Racke MK. PPAR-gamma: Therapeutic Potential for Multiple Sclerosis. Ppar Research. 2008: 627463. PMID 18604287 DOI: 10.1155/2008/627463 |
0.379 |
|
| 2008 |
Kielian T, Syed MM, Liu S, Phulwani NK, Phillips N, Wagoner G, Drew PD, Esen N. The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses. Journal of Immunology (Baltimore, Md. : 1950). 180: 5004-16. PMID 18354226 DOI: 10.4049/Jimmunol.180.7.5004 |
0.349 |
|
| 2007 |
Xu J, Racke MK, Drew PD. Peroxisome proliferator-activated receptor-alpha agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis. Journal of Neurochemistry. 103: 1801-10. PMID 17727629 DOI: 10.1111/J.1471-4159.2007.04875.X |
0.377 |
|
| 2007 |
Xu J, Drew PD. Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia. Journal of Immunology (Baltimore, Md. : 1950). 178: 1904-13. PMID 17237441 DOI: 10.4049/Jimmunol.178.3.1904 |
0.362 |
|
| 2007 |
Zhang-Gandhi CX, Drew PD. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. Journal of Neuroimmunology. 183: 50-9. PMID 17175031 DOI: 10.1016/J.Jneuroim.2006.11.007 |
0.436 |
|
| 2006 |
Xu J, Chavis JA, Racke MK, Drew PD. Peroxisome proliferator-activated receptor-alpha and retinoid X receptor agonists inhibit inflammatory responses of astrocytes. Journal of Neuroimmunology. 176: 95-105. PMID 16764943 DOI: 10.1016/J.Jneuroim.2006.04.019 |
0.404 |
|
| 2006 |
Drew PD, Xu J, Storer PD, Chavis JA, Racke MK. Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders. Neurochemistry International. 49: 183-9. PMID 16753239 DOI: 10.1016/J.Neuint.2006.04.003 |
0.406 |
|
| 2006 |
Racke MK, Gocke AR, Muir M, Diab A, Drew PD, Lovett-Racke AE. Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis. The Journal of Nutrition. 136: 700-3. PMID 16484546 DOI: 10.1093/Jn/136.3.700 |
0.413 |
|
| 2006 |
Xu J, Drew PD. 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. Journal of Neuroimmunology. 171: 135-44. PMID 16303184 DOI: 10.1016/J.Jneuroim.2005.10.004 |
0.381 |
|
| 2005 |
Xu J, Storer PD, Chavis JA, Racke MK, Drew PD. Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia. Journal of Neuroscience Research. 81: 403-11. PMID 15968640 DOI: 10.1002/Jnr.20518 |
0.411 |
|
| 2005 |
Drew PD, Storer PD, Xu J, Chavis JA. Hormone regulation of microglial cell activation: relevance to multiple sclerosis. Brain Research. Brain Research Reviews. 48: 322-7. PMID 15850670 DOI: 10.1016/J.Brainresrev.2004.12.020 |
0.417 |
|
| 2005 |
Storer PD, Xu J, Chavis J, Drew PD. Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. Journal of Neuroimmunology. 161: 113-22. PMID 15748950 DOI: 10.1016/J.Jneuroim.2004.12.015 |
0.445 |
|
| 2005 |
Storer PD, Xu J, Chavis JA, Drew PD. Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis. Journal of Neuroscience Research. 80: 66-74. PMID 15723383 DOI: 10.1002/Jnr.20413 |
0.41 |
|
| 2004 |
Kielian T, McMahon M, Bearden ED, Baldwin AC, Drew PD, Esen N. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). Journal of Neurochemistry. 90: 1163-72. PMID 15312171 DOI: 10.1111/J.1471-4159.2004.02579.X |
0.379 |
|
| 2004 |
Lovett-Racke AE, Hussain RZ, Northrop S, Choy J, Rocchini A, Matthes L, Chavis JA, Diab A, Drew PD, Racke MK. Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. Journal of Immunology (Baltimore, Md. : 1950). 172: 5790-8. PMID 15100326 DOI: 10.4049/Jimmunol.172.9.5790 |
0.441 |
|
| 2004 |
Diab A, Hussain RZ, Lovett-Racke AE, Chavis JA, Drew PD, Racke MK. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 148: 116-26. PMID 14975592 DOI: 10.1016/J.Jneuroim.2003.11.010 |
0.378 |
|
| 2003 |
Drew PD, Chavis JA, Bhatt R. Sex steroid regulation of microglial cell activation: relevance to multiple sclerosis. Annals of the New York Academy of Sciences. 1007: 329-34. PMID 14993065 DOI: 10.1196/Annals.1286.031 |
0.354 |
|
| 2003 |
Kielian T, Drew PD. Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation. Journal of Neuroscience Research. 71: 315-25. PMID 12526021 DOI: 10.1002/Jnr.10501 |
0.415 |
|
| 2002 |
Diab A, Deng C, Smith JD, Hussain RZ, Phanavanh B, Lovett-Racke AE, Drew PD, Racke MK. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 168: 2508-15. PMID 11859145 DOI: 10.4049/Jimmunol.168.5.2508 |
0.44 |
|
| 2001 |
Drew PD, Chavis JA. The cyclopentone prostaglandin 15-deoxy-Δ12,14 prostaglandin J2 represses nitric oxide, TNF-α, and IL-12 production by microglial cells Journal of Neuroimmunology. 115: 28-35. PMID 11282151 DOI: 10.1016/S0165-5728(01)00267-3 |
0.433 |
|
| 2000 |
Barger SW, Chavis JA, Drew PD. Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. Journal of Neuroscience Research. 62: 503-9. PMID 11070493 DOI: 10.1002/1097-4547(20001115)62:4<503::Aid-Jnr4>3.0.Co;2-A |
0.342 |
|
| 2000 |
Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation Journal of Neuroimmunology. 111: 77-85. PMID 11063824 DOI: 10.1016/S0165-5728(00)00386-6 |
0.392 |
|
| 2000 |
Drew PD, Chavis JA. Inhibition of microglial cell activation by cortisol Brain Research Bulletin. 52: 391-396. PMID 10922518 DOI: 10.1016/S0361-9230(00)00275-6 |
0.362 |
|
| 1995 |
Drew PD, Franzoso G, Becker KG, Bours V, Carlson LM, Siebenlist U, Ozato K. NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 15: 1037-45. PMID 8746784 DOI: 10.1089/Jir.1995.15.1037 |
0.345 |
|
| 1995 |
Drew PD, Franzoso G, Carlson LM, Biddison WE, Siebenlist U, Ozato K. Interferon regulatory factor-2 physically interacts with NF-kappa B in vitro and inhibits NF-kappa B induction of major histocompatibility class I and beta 2-microglobulin gene expression in transfected human neuroblastoma cells. Journal of Neuroimmunology. 63: 157-62. PMID 8550813 DOI: 10.1016/0165-5728(95)00140-9 |
0.32 |
|
| 1994 |
Atwood WJ, Tornatore CS, Traub R, Conant K, Drew PD, Major EO. Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells. Aids Research and Human Retroviruses. 10: 1207-11. PMID 7848678 DOI: 10.1089/Aid.1994.10.1207 |
0.339 |
|
| 1993 |
Segars JH, Nagata T, Bours V, Medin JA, Franzoso G, Blanco JCG, Drew PD, Becker KG, An J, Tang T, Stephany DA, Neel B, Siebenlist U, Ozato K. Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-κB (p50-p65) and retinoic acid receptor β-retinoid X receptor β heterodimers Molecular and Cellular Biology. 13: 6157-6169. PMID 8413217 DOI: 10.1128/Mcb.13.10.6157 |
0.327 |
|
| Show low-probability matches. |